Schedule 13G ownership disclosure
Celldex Therapeutics, Inc.
Security class unavailable · CUSIP: 15117B103
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,424,420
- Percent of class
- 7.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001445546-16-006494
- Form type
- SC 13G
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- Jan 27, 2016
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership